JPMA Gearing Up for Drug Pricing Reform Debate towards December: Exec

JPMA Director General Kenshi Kinoshita (right), Senior Managing Director Kazuhiko Mori The Japan Pharmaceutical Manufacturers Association (JPMA) is set to closely watch the ongoing debates over the FY2024 drug pricing reform, while reorganizing its requests to press for a shift...read more